Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer
Position
Chief Medical Officer
Company
Tarsus Pharmaceuticals
IrvineManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Tarsus Pharmaceuticals, Inc has appointed Dr Elizabeth Yeu, MD, as the new Chief Medical Officer effective Monday. Dr Yeu brings extensive experience to her new role, having been a Partner at Virginia Eye Consultants and an Assistant Professor of Ophthalmology at Eastern Virginia Medical School. Her leadership roles in the field highlight her expertise.
Quick answer
Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024). Tarsus Pharmaceuticals is based in Irvine, California, United States.
- Who is the new Chief Medical Officer at Tarsus Pharmaceuticals?
- Tarsus Pharmaceuticals named Elizabeth Yeu Chief Medical Officer, announced November 5, 2024.
- What did Tarsus Pharmaceuticals announce on November 5, 2024?
- Tarsus Pharmaceuticals, Inc has appointed Dr Elizabeth Yeu, MD, as the new Chief Medical Officer effective Monday. Dr Yeu brings extensive experience to her new role, having been a Partner at Virginia Eye Consultants and an Assistant Professor of Ophthalmology at Eastern Virginia Medical School.
- What does Tarsus Pharmaceuticals do?
- Tarsus Pharmaceuticals, Inc. is a company specializing in biological products.
- Where is Tarsus Pharmaceuticals based?
- Tarsus Pharmaceuticals is based in Irvine, California, United States.
- Which similar companies made leadership changes around the same time?
- Alkeus Pharmaceuticals (October 31, 2024), Arecor Therapeutics PLC (November 18, 2024), NRx Pharmaceuticals (November 18, 2024) and BerGenBio ASA (November 20, 2024) also announced leadership changes within 45 days of Tarsus Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- BerGenBio Appoints Olav Hellebø as CEO (November 20, 2024)
- TORL BioTherapeutics Appoints Aran Maree, MD, as Chief Medical Officer and Initiates Global Phase 2 Study of TORL-1-23 (December 2, 2024)
- Catherine Owen Adams Succeeds Steve Davis as CEO at Acadia Pharmaceuticals Inc. (September 23, 2024)
Who to call at Tarsus Pharmaceuticals, and when
A new leader at Tarsus Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Tarsus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tarsus Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tarsus Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tarsus Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tarsus Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.